Drug
Tocilizumab-aazg
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Hepatic Cytolysis | 6 | 22.6 | 22.9 | signal |
| 2 | Agranulocytosis | 7 | 17.5 | 17.7 | signal |
| 3 | Product Substitution Issue | 21 | 16.8 | 17.6 | signal |
| 4 | Injection Site Urticaria | 5 | 9.5 | 9.6 | signal |
| 5 | Injection Site Warmth | 4 | 9.0 | 9.0 | signal |
| 6 | Device Defective | 3 | 8.5 | 8.6 | signal |
| 7 | Injection Site Rash | 4 | 6.1 | 6.1 | signal |
| 8 | Injection Site Pruritus | 8 | 5.5 | 5.6 | signal |